Legal & General Group’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.6M | Sell |
75,640
-12,271
| -14% | -$647K | ﹤0.01% | 1665 |
|
|
2025
Q4 | $4.61M | Sell |
87,911
-4,568
| -5% | -$274K | ﹤0.01% | 1597 |
|
|
2025
Q3 | $5.99M | Sell |
92,479
-37,088
| -29% | -$2.13M | ﹤0.01% | 1471 |
|
|
2025
Q2 | $6.3M | Buy |
129,567
+48,412
| +60% | +$1.87M | ﹤0.01% | 1436 |
|
|
2025
Q1 | $2.76M | Sell |
81,155
-16,649
| -17% | -$706K | ﹤0.01% | 1805 |
|
|
2024
Q4 | $3.85M | Sell |
97,804
-625
| -0.6% | -$29.5K | ﹤0.01% | 1704 |
|
|
2024
Q3 | $4.62M | Buy |
98,429
+4,337
| +5% | +$220K | ﹤0.01% | 1609 |
|
|
2024
Q2 | $5.08M | Buy |
94,092
+11,182
| +13% | +$647K | ﹤0.01% | 1518 |
|
|
2024
Q1 | $5.65M | Buy |
82,910
+15,847
| +24% | +$1.13M | ﹤0.01% | 1449 |
|
|
2023
Q4 | $4.2M | Sell |
67,063
-87
| -0.1% | -$4.81K | ﹤0.01% | 1613 |
|
|
2023
Q3 | $3.05M | Buy |
67,150
+2,715
| +4% | +$140K | ﹤0.01% | 1698 |
|
|
2023
Q2 | $3.62M | Buy |
64,435
+3,341
| +5% | +$190K | ﹤0.01% | 1634 |
|
|
2023
Q1 | $2.76M | Buy |
61,094
+6,039
| +11% | +$293K | ﹤0.01% | 1730 |
|
|
2022
Q4 | $2.24M | Buy |
55,055
+619
| +1% | +$32.8K | ﹤0.01% | 1830 |
|
|
2022
Q3 | $3.56M | Sell |
54,436
-870
| -2% | -$63K | ﹤0.01% | 1550 |
|
|
2022
Q2 | $3.36M | Buy |
55,306
+2,629
| +5% | +$155K | ﹤0.01% | 1615 |
|
|
2022
Q1 | $3.31M | Buy |
52,677
+675
| +1% | +$42.4K | ﹤0.01% | 1758 |
|
|
2021
Q4 | $3.94M | Buy |
52,002
+4,311
| +9% | +$377K | ﹤0.01% | 1694 |
|
|
2021
Q3 | $5.34M | Buy |
47,691
+11,926
| +33% | +$1.5M | ﹤0.01% | 1514 |
|
|
2021
Q2 | $5.79M | Buy |
35,765
+2,530
| +8% | +$308K | ﹤0.01% | 1469 |
|
|
2021
Q1 | $4.05M | Buy |
33,235
+3,854
| +13% | +$582K | ﹤0.01% | 1674 |
|
|
2020
Q4 | $4.5M | Sell |
29,381
-1,218
| -4% | -$144K | ﹤0.01% | 1509 |
|
|
2020
Q3 | $2.56M | Buy |
30,599
+4,221
| +16% | +$374K | ﹤0.01% | 1667 |
|
|
2020
Q2 | $1.94M | Buy |
26,378
+17,301
| +191% | +$1.01M | ﹤0.01% | 1745 |
|
|
2020
Q1 | $428K | Sell |
9,077
-24,753
| -73% | -$1.28M | ﹤0.01% | 2114 |
|
|
2019
Q4 | $2.06M | Buy |
33,830
+32,745
| +3,018% | +$1.79M | ﹤0.01% | 1786 |
|
|
2019
Q3 | $44K | Hold |
1,085
| – | – | ﹤0.01% | 2787 |
|
|
2019
Q2 | $51K | Buy |
1,085
+545
| +101% | +$21.8K | ﹤0.01% | 2770 |
|
|
2019
Q1 | $19K | Hold |
540
| – | – | ﹤0.01% | 3109 |
|
|
2018
Q4 | $15K | Buy |
540
+349
| +183% | +$12.1K | ﹤0.01% | 3179 |
|
|
2018
Q3 | $8K | Hold |
191
| – | – | ﹤0.01% | 3341 |
|
|
2018
Q2 | $11K | Buy |
+191
| New | +$10.9K | ﹤0.01% | 3290 |
|
Other funds holding CRSP
AIM
OAG
GP
SOCM
